Home › Osteosarcoma
Pag-aaral pangklinika para sa Osteosarcoma na nagre-recruit sa U.S.
52 pag-aaral para sa Osteosarcoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- St. Louis, MO10 pag-aaral
- Memphis, TN10 pag-aaral
- Atlanta, GA10 pag-aaral
- Boston, MA9 pag-aaral
- Mountain View, CA8 pag-aaral
- Houston, TX7 pag-aaral
- Chicago, IL7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Birmingham, AL7 pag-aaral
- Philadelphia, PA6 pag-aaral
- Cincinnati, OH6 pag-aaral
- Washington, DC6 pag-aaral
- New York City, NY6 pag-aaral
- Aurora, CO6 pag-aaral
- Tampa, FL6 pag-aaral
- Durham, NC5 pag-aaral
- Dallas, TX5 pag-aaral
- The Bronx, NY5 pag-aaral
- Honolulu, HI5 pag-aaral
- Gainesville, FL4 pag-aaral
- Baltimore, MD4 pag-aaral
- Columbus, OH4 pag-aaral
- Oakland, CA4 pag-aaral
- Seattle, WA4 pag-aaral
- San Diego, CA4 pag-aaral
- San Francisco, CA4 pag-aaral
- Harrisburg, PA4 pag-aaral
- Queens, NY4 pag-aaral
- Orlando, FL4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Clifton, NJ4 pag-aaral
- Cleveland, OH4 pag-aaral
- Madison, WI3 pag-aaral
- Milwaukee, WI3 pag-aaral
- Jacksonville, FL3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- St. Petersburg, FL3 pag-aaral
- Portland, OR3 pag-aaral
- Orange, CA3 pag-aaral
- Minneapolis, MN3 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona5 pag-aaral
- Arkansas3 pag-aaral
- California18 pag-aaral
- Colorado6 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia5 pag-aaral
- Florida10 pag-aaral
- Georgia10 pag-aaral
- Hawaii5 pag-aaral
- Illinois7 pag-aaral
- Louisiana3 pag-aaral
- Maryland5 pag-aaral
- Massachusetts9 pag-aaral
- Michigan6 pag-aaral
- Minnesota3 pag-aaral
- Missouri10 pag-aaral
- New Jersey6 pag-aaral
- New York11 pag-aaral
- North Carolina6 pag-aaral
- Ohio12 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania9 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina3 pag-aaral
- Tennessee12 pag-aaral
- Texas10 pag-aaral
- Utah4 pag-aaral
- Virginia3 pag-aaral
- Washington4 pag-aaral
- Wisconsin5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma
Nagre-recruitPhase 2
Edad 7 hanggang 22 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07560826Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04616560Clinical Orthopaedic Data Bank (Acute and Chronic)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 3, 2026 · NCT00411060Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Nagre-recruitPhase 1/2
Edad 12 hanggang 40 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07725380Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Nagre-recruitPhase 1
Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06156410Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Nagre-recruitPhase 1
Edad 1 hanggang 75 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07227571Losartan + Sunitinib in Treatment of Osteosarcoma
Nagre-recruitPhase 1
Edad 10 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT03900793Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07428993Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Nagre-recruitPhase 3
Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05235165Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07514819SPEARHEAD-3 Pediatric Study
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455Musculoskeletal Cancers Remote Monitoring and Care
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07129226Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05210374NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07628634Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT04040205AOH1996 for the Treatment of Refractory Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT05227326NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
Nagre-recruitPhase 1
Edad 1 hanggang 24 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT07211737Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Nagre-recruitPhase 1
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT03093909Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Nagre-recruitPhase 2
Edad 0 hanggang 50 · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06625190XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06571734Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.